Effects of cognitive stimulation therapy Japanese version (CST-J) for people with dementia: A single-blind, controlled clinical trial

Aging and Mental Health

Volumn 17, Issue 5, 2013, Pages 579-586

  Yamanaka, Katsuo ^a   Kawano, Yoshiyuki ^a   Noguchi, Dai ^a   Nakaaki, Shutaro ^b   Watanabe, Norio ^b   Amano, Takashi ^c   Spector, Aimee ^d  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^c Dia Foundation for Research on Ageing Societies   (Japan)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Day program; Intention to treat analysis; Long term care; Nonpharmacological therapy

Indexed keywords

AFFECT; ARTICLE; COGNITIVE THERAPY; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMENTIA; FEMALE; HUMAN; JAPAN; MALE; METHODOLOGY; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; SEX RATIO; SINGLE BLIND PROCEDURE; TREATMENT OUTCOME; VERY ELDERLY;

AFFECT; AGED, 80 AND OVER; COGNITIVE THERAPY; DEMENTIA; FEMALE; HUMANS; MALE; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; SINGLE-BLIND METHOD; TOKYO; TREATMENT OUTCOME;

EID: 84880165640     PISSN: 13607863     EISSN: 13646915     Source Type: Journal    
DOI: 10.1080/13607863.2013.777395     Document Type: Article

References (48)

1. Alzheimer's Disease International. (2010). World Alzheimer Report 2010. Retrieved from http://www.alz.org/documents/national/World-Alzheimer-Report- 2010.pdf
2. Ballesteros, R.F. (2007). Quality of life, life satisfaction, and positive aging. In R.F. Ballesteros (Ed.), Geropsychology: European perspectives for an aging world (pp. 197-223). Cambridge: Hogrefe & Huber.
3. Birks, J. (2006). Cholinesterase inhibitors for Alzheimer's disease. Cochrane Database of Systematic Reviews, 1, CD005593.
4. Brown, H., & Prescott, R. (1999). Generalised linear mixed models. In H. Brown & R. Prescott (Eds.), Applied mixed models in medicine (pp. 103-147). New York: John Wiley.
5. Buckley, T., Fauth, E.B., Morrison, A., Tschanz, J., Rabins, P. V., Piercy, K.W., . . . Lyketsos, C.G. (2012). Predictors of quality of life ratings for persons with dementia simultaneously reported by patients and their caregivers: The Cache County (Utah) Study. International Psychogeriatrics, 24, 1094-1102.
6. Clare, L. (2008). Awareness and the person with dementia. In L. Clare (Ed.), Neuropsychological rehabilitation and people with dementia (pp. 39-51). New York: Psychology Press.
7. Clare, L., & Woods, B. (2004). Cognitive training and cognitive rehabilitation for people with early stage Alzheimer's disease: A review. Neuropsychological Rehabilitation, 14, 385-401.
8. Cooper, C., Mukadam, N., Katona, C., Lyketsos, C.G., Ames, D., Rabins, P., . . . World Federation of Biological Psychiatry -Old Age Taskforce. (2012). Systematic review of the effectiveness of non-pharmacological interventions to improve quality of life of people with dementia. International Psychogeriatrics, 24, 856-870.
9. Eckroth-Bucher, M., & Siberski, J. (2009). Preserving cognition through an integrated cognitive stimulation and training program. American Journal of Alzheimer's Disease and Other Dementias, 24, 234-245.
10. EuroQol Group. (1990). EuroQol: A new facility for the measurement of health-related quality of life. Health Policy, 16, 199-208.
11. Faul, F., Erdfelder, E., & Buchner, A.L. (2007). G-Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behavior Research Methods, 39, 175-191.
12. Folstein, M.F., Folstein, S.E., & McHugh, P.R. (1975). 'Minimental state'. A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12, 189-198.
13. Food and Drug Administration. (2005). FDA public health advisory: Deaths with antipsychotics in elderly patients with behavioral disturbances. Retrieved from http://www.fda.gov/Drugs/DrugSafety/ PostmarketDrugSafetyInformationforPatientsandProviders/ DrugSafetyInformationforHeathcareProfessionals/PublicHealthAdvisories/ucm053171. htm.
14. Gallup. (2010). Gallup global wellbeing: The behavioral economics of GDP growth. Washington, DC: Author.
15. Garrard, P., Patterson, K., & Hodges, J.R. (2005). Semantic processing in Alzheimer's disease. In R.G. Morris & G.T. Becker (Eds.), Cognitive neuropsychology of Alzheimer's disease (2nd ed., pp. 179-196). Oxford: Oxford University Press.
16. Heine, S., & Lehman, D.R. (1997). Culture, dissonance, and selfaffirmation. Personality and Social Psychology Bulletin, 23, 389-400.
17. Higgins, J.P.T., & Green, S. (Eds.). (2011). Cochrane handbook for systematic reviews of interventions, version 5.1.0. Retrieved from http://www.cochrane-handbook.org.
18. Hughes, C.P., Berg, L., Danziger, W.L., Coben, L.A., & Martin, R.L. (1982). A new clinical scale for the staging of dementia. British Journal of Psychiatry, 140, 566-572.
19. Japanese EuroQol Translation Team. (1998). The development of the Japanese EuroQol instrument. Journal of Health Care and Society, 8, 109-123. (in Japanese).
20. Japanese Society of Neurology. (2010). The clinical guideline for dementing disorder. Tokyo: Igakushoin. (in Japanese)
21. Karasawa, M. (1997). A Japanese perception of self and others: Self-critical and other-enhancing biases. Culture, dissonance, and self-affirmation. Japanese Journal of Psychology, 72, 195-203. (in Japanese).
22. Kitayama, S., Markus, H.R., Matsumoto, H., & Norasakkunkit, V. (1997). Individual and collective processes in the construction of the self: Self-enhancement in the United States and self-criticism in Japan. Journal of Personality and Social Psychology, 72, 1245-1267.
23. Kitwood, T. (1997). Dementia reconsidered: The person comes first. Buckingham: Open University Press.
24. Knapp, M., Thorgrimsen, L., Patel, A., Spector, A., Hallam, A., Woods, B., & Orrell, M. (2006). Cognitive stimulation therapy for people with dementia: Cost effectiveness analysis. British Journal of Psychiatry, 188, 574-580.
25. Livingston, G., Johnston, K., Katona, C., Paton, J., & Lyketsos, C.G. (2005). Systematic review of psychological approaches to the management of neuropsychiatric symptoms of dementia. American Journal of Psychiatry, 162, 1996-2021.
26. Logsdon, R., Gibbons, L.E., McCurry, S.M., & Teri, L. (1999). Quality of life in Alzheimer's disease: Patient and caregiver reports. Journal of Mental Health and Aging, 5, 21-32.
27. Lorish, C.D., & Maisiak, R. (1986). The face scale: A brief, nonverbal method for assessing patient mood. Arthritis & Rheumatism, 29, 906-909.
28. Matsuda, O. (2007). Cognitive stimulation therapy for Alzheimer's disease: The effect of cognitive stimulation therapy on the progression of mild Alzheimer's disease in patients treated with donepezil. International Psychogeriatrics, 19, 241-252.
29. Matsuda, O., & Nakatani, M. (2004). Manual for Japanese version of the Neurobehavioral Cognitive Status Examination (COGNISTAT). Tokyo: World Planning. (in Japanese).
30. Matsuda, O., Shido, E., Hashikai, A., Shibuya, H., Kouno, M., Hara, C., & Saito, M. (2010). Short-term effect of combined drug therapy and cognitive stimulation therapy on the cognitive function of Alzheimer's disease. Psychogeriatrics, 10, 167-172.
31. Matsui, T., Nakaaki, S., Murata, Y., Sato, J., Shinagawa, Y., Tatsumi, H., & Furukawa, T.A. (2006). Determinants of the quality of life in Alzheimer's disease patients as assessed by the Japanese version of the Quality of Life-Alzheimer's disease scale. Dementia and Geriatric Cognitive Disorders, 21, 182-191.
32. Mochizuki-Kawai, H., Kawamura, M., Hasegawa, Y., Mochizuki, S., Oeda, R., Yamanaka, K., & Tagaya, H. (2004). Deficits in long-term retention of learned motor skills in patients with cortical or subcortical degeneration. Neuropsychologia, 42, 1858-1863.
33. National Institute for Health and Clinical Excellence and the Social Care Institute for Excellence (NICE-SCIE). (2006). Dementia: Supporting people with dementia and their carers in health and social care. NICE Clinical Guideline 42. Retrieved from http://www.nice.org.uk
34. Northern California Neurobehavioral Group. (1995). Neurobehavioral Cognitive Status Examination (COGNISTAT). Fairfax, CA: Author.
35. Olazaran, J., Reisberg, B., Clare, L., Cruz, I., Peña-Casanova, J., del Ser, T., . . . Muñiz, R. (2010). Nonpharmacological therapies in Alzheimer's disease: A systematic review of efficacy. Dementia and Geriatric Cognitive Disorders, 30, 161-178.
36. Orrell, M., Yates, L.A., Burns, A., Russell, I., Woods, R.T., Hoare, Z., . . . Orgeta, V. (2012). Individual Cognitive Stimulation Therapy for dementia (iCST): Study protocol for a randomized controlled trial. Trials, 13, 172.
37. Overman, A.A., & Becker, J.T. (2005). Information processing defects in episodic memory in Alzheimer's disease. In R.G. Morris & G.T. Becker (Eds.). Cognitive neuropsychology of Alzheimer's disease (2nd ed., pp. 121-140). Oxford: Oxford University Press.
38. Spector, A., Orrell, M., Davies, S., & Woods, B. (1998). Reality orientation for dementia: A review of the evidence for its effectiveness. Cochrane Database of Systematic Reviews, 4, CD001119.
39. Spector, A., Orrell, M., Davies, S., & Woods, B. (2001). Can reality orientation be rehabilitated?: Development and piloting of an evidence-based programme of cognition-based therapies for people with dementia. Neuropsychological Rehabilitation, 11, 377-397.
40. Spector, A., Thorgrimsen, L., Woods, B., Royan, L., Davies, S., Butterworth, M., & Orrell, M. (2003). Efficacy of an evidence-based cognitive stimulation therapy programme for people with dementia: Randomised controlled trial. British Journal of Psychiatry, 183, 248-254.
41. SPSS. (2010). IBM SPSS Statistics for Windows 19.0J ed. Tokyo: Author.
42. Steis, M.R., & Schrauf, R.W. (2009). A review of translations and adaptations of the Mini-Mental State Examination in languages other than English and Spanish. Research in Gerontological Nursing, 2, 214-224.
43. Tabira, Y., Yasunaga, M., Nagamoto, N., Matsushita, H., Fukunaga, Y., Ihara, T., & Kawasuji, M. (2002). Quality of life after esophagectomy for cancer: An assessment using the questionnaire with the face scale. Surgery Today, 32, 213-219.
44. Thorgrimsen, L., Selwood, A., Spector, A., Royan, L., de Madariaga Lopez, M., Woods, R.T., & Orrell, M. (2003). Whose quality of life is it anyway? The validity and reliability of the Quality of Life - Alzheimer's Disease (QOL-AD) scale. Alzheimer's Disease and Associated Disorders, 17, 201-208.
45. Van der Mussele, S., Bekelaar, K., Le Bastard, N., Vermeiren, Y., Saerens, J., Somers, N., . . . Engelborghs, S. (2012). Prevalence and associated behavioral symptoms of depression in mild cognitive impairment and dementia due to Alzheimer's disease. International Journal of Geriatric Psychiatry, doi: 10.1002/gps.3909 [Epub ahead of print].
46. Vidovich, M.R., Shaw, J., Flicker, L., & Almeida, O.P. (2011). Cognitive activity for the treatment of older adults with mild Alzheimer's Disease (AD) - PACE-AD: Study protocol for a randomised controlled trial. Trials, 12, 47.
47. Wolf, M.M. (1978). Social validity: The case for subjective measurement or how applied behavior analysis is finding its heart. Journal of Applied Behavior Analysis, 11, 203-214.
48. Woods, B. (1999). The person in dementia care. Generations, 23, 35-39.